1. Home
  2. FFBC vs ERAS Comparison

FFBC vs ERAS Comparison

Compare FFBC & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

HOLD

Current Price

$34.49

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$18.72

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFBC
ERAS
Founded
1863
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.0B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
FFBC
ERAS
Price
$34.49
$18.72
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
$30.71
$14.25
AVG Volume (30 Days)
1.0M
5.5M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.34%
N/A
EPS Growth
10.83
36.23
EPS
0.71
N/A
Revenue
N/A
N/A
Revenue This Year
$27.67
N/A
Revenue Next Year
$4.58
N/A
P/E Ratio
$47.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.09
$1.33
52 Week High
$35.00
$24.28

Technical Indicators

Market Signals
Indicator
FFBC
ERAS
Relative Strength Index (RSI) 65.20 67.85
Support Level $29.32 $12.36
Resistance Level $35.00 $24.28
Average True Range (ATR) 0.71 1.20
MACD 0.01 0.22
Stochastic Oscillator 85.30 77.71

Price Performance

Historical Comparison
FFBC
ERAS

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending, and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and non-interest-bearing accounts, time deposits, and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: